Remove 2022 Remove Medicare Remove Prescription Drug Pricing Remove Public Health
article thumbnail

How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

Health Populi

What happens to a health care ecosystem when the volume of patients and revenues they generate decline? How would that further impact the micro-economy of health care? A report from Trilliant on the 2022 Trends Shaping the Health Economy helps to inform our response to that question. In the U.S.,

article thumbnail

Health Provider News – July 22, 2022

Hall Render

CMS releases Medicare OPPS and ASC proposed rule. Amazon to buy primary health-care provider One Medical for roughly $3.9 Covid-19 public health emergency extended in the US. Healthcare Merger and Acquisition Activity Generates $19B in Q2 2022. Lamont: Changing federal health guidelines hindered CT in pandemic.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

How 5 health systems are spending their innovation investment dollars. The 55 hospitals penalized by Medicare 8 years straight over patient complications. U of California, Irvine to Launch Institute for Precision Health. Pandemic’s mental health crisis shows California needs to reinvent health care.

article thumbnail

Health Provider News – February 18, 2022

Hall Render

13-year Medicare payment dispute will return to HHS, court rules. Lawmakers call on Biden to end public health emergency. Only 14% of Hospitals Met Price Transparency Rule Compliance. A layoff list, expired medicine, neglected patients: Illinois hospital loses Medicare contract. of Public Health website.

article thumbnail

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Healthcare Law Blog

The Rebate Programs are administered as part of the prescription drug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]

article thumbnail

Health Provider News – November 11, 2022

Hall Render

Like ordering from Amazon: Where health tech is heading, according to 3 CIOs. Medical groups to Biden: ED boarding at a ‘crisis point’ Nursing home groups request public health emergency extension. Physician leaders balk at Medicare 4.48% physician fee cut. in prescription drug pricing case.

article thumbnail

Spending on Medicines In and Post-COVID Say a Lot About Patients and Larger Healthcare Trends – an IQVIA Update

Health Populi

As such, the debate on prescription drug pricing in the U.S. is heating up, with President Biden mentioning the scenario of Medicare negotiating drug prices with pharmaceutical manufacturers in his latest speech measuring progress at 100 days in the White House.